gastrointestinal barrier permeability
Showing 1 - 25 of 7,003
Aging and Gastrointestinal Barrier Function
Not yet recruiting
- Aging
- Hyperthermia
- Controlled hyperthermia
- (no location specified)
Apr 3, 2023
Gastrointestinal Post Acute COVID-19 Syndrome Trial in Taipei (Confocal laser endomicroscopy)
Recruiting
- Gastrointestinal Post Acute COVID-19 Syndrome
- Confocal laser endomicroscopy
-
Taipei, TaiwanDivision of Gastroenterology, Department of Medicine, Taipei Vet
Nov 9, 2022
Diabetes, Type 2, Stroke (CVA) or Transient Ischemic Attack Trial in Seattle (Semaglutide Auto-Injector, Placebo)
Not yet recruiting
- Diabetes Mellitus, Type 2
- Stroke (CVA) or Transient Ischemic Attack
- Semaglutide Auto-Injector
- Placebo
-
Seattle, WashingtonUniversity of Washington - Harborview Medical Center
Mar 10, 2023
Ulcerative Colitis, Healthy, Irritable Bowel Syndrome With Diarrhea Trial in Ann Arbor (Aquamin)
Recruiting
- Ulcerative Colitis
- +2 more
-
Ann Arbor, MichiganUniversity of Michigan Hospital
Nov 4, 2022
Microscopic Colitis Trial in Örebro (Dietary fibre, Placebo compound)
Recruiting
- Microscopic Colitis
- Dietary fibre
- Placebo compound
-
Örebro, Örebro Län, SwedenÖrebro University
Apr 20, 2022
Irritable Bowel Syndrome Trial in Rouen (colonoscopy with biopsies in the left colon to assess intestinal permeability)
Completed
- Irritable Bowel Syndrome
- colonoscopy with biopsies in the left colon to assess intestinal permeability
-
Rouen, FranceRouen University Hospital
May 19, 2022
Gastroparesis, Healthy Trial in Jacksonville (Labs, urine tests, upper endoscopy with biopsy and confocal laser endomicroscopy)
Suspended
- Gastroparesis
- Healthy
- Labs, urine tests, upper endoscopy with biopsy and confocal laser endomicroscopy
-
Jacksonville, FloridaMayo Clinic in Florida
Apr 6, 2022
Type 2 Diabetes, Chronic Inflammation, Intestinal Permeability Trial in Aurora (Semaglutide, Placebo)
Recruiting
- Type 2 Diabetes
- +2 more
- Semaglutide
- Placebo
-
Aurora, ColoradoUniversity of Colorado Anschutz
Apr 12, 2022
Obesity, Circadian Dysregulation Trial in Lincoln, Omaha (Blueberry powder, Placebo powder)
Active, not recruiting
- Obesity
- Circadian Dysregulation
- Blueberry powder
- Placebo powder
-
Lincoln, Nebraska
- +1 more
Dec 6, 2022
Diverticulitis Trial in Rochester (High-dose prebiotic, Low-dose prebiotic, Placebo)
Suspended
- Diverticulitis
- High-dose prebiotic
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Mar 11, 2022
Xerosis Due to Atopic Dermatitis Trial in Winston-Salem (Cetaphil Pro Eczema moisturizer, Electronic interaction, GPSkin)
Active, not recruiting
- Xerosis Due to Atopic Dermatitis
- Cetaphil Pro Eczema moisturizer
- +2 more
-
Winston-Salem, North CarolinaWake Forest University Health Sciences Department of Dermatology
Dec 21, 2022
Diabetes, Type 2, Metformin Adverse Reaction Trial in Zabrze (Sanprobi Barrier-multispecies probiotic, Placebo Comparator)
Completed
- Diabetes Mellitus, Type 2
- Metformin Adverse Reaction
- Sanprobi Barrier-multispecies probiotic
- Placebo Comparator
-
Zabrze, PolandDepartment of Internal Diseases, Diabetology and Nephrology
May 5, 2022
Pathophysiology of Post-Infectious Functional GI Disorders
Completed
- Campylobacter Infections
- Irritable Bowel Syndrome
- DNA Analysis of Blood Sample
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 19, 2022
Gastrointestinal Injury, Acute Mountain Sickness Trial in Natick (FP, Placebo, High altitude)
Recruiting
- Gastrointestinal Injury
- Acute Mountain Sickness
- FP
- +3 more
-
Natick, MassachusettsUSARIEM
Nov 16, 2021
Low Grade Glioma of Brain Trial in Santa Monica (Focused Ultrasound)
Recruiting
- Low Grade Glioma of Brain
- Focused Ultrasound
-
Santa Monica, CaliforniaNeurological Associates of West LA
Aug 30, 2021
Elderly, Bowel Symptoms, Prebiotics Trial in Örebro (yeast-beta glucan)
Completed
- Elderly
- +2 more
- yeast-beta glucan
-
Örebro, SwedenCampus USÖ, Örebro University
Oct 13, 2022
Multiple Sclerosis Trial in Nashville (Natalizumab 300 MG in 15 ML Injection)
Recruiting
- Multiple Sclerosis
- Natalizumab 300 MG in 15 ML Injection
-
Nashville, TennesseeVanderbilt University Medical Center
Jan 8, 2022
Irritable Bowel Syndrome, Visceral Hypersensitivity Trial in Jacksonville, Rochester (Gastrointestinal Permeability Test, Upper
Completed
- Irritable Bowel Syndrome
- Visceral Hypersensitivity
- Gastrointestinal Permeability Test
- +2 more
-
Jacksonville, Florida
- +1 more
Sep 2, 2021
Stress, Psychological Trial in Leuven (Prebiotic, L-Tryptophan, Placebo)
Recruiting
- Stress, Psychological
- Prebiotic
- +2 more
-
Leuven, Vlaams-Brabant, BelgiumKU Leuven/ UZ Leuven
Oct 17, 2023
Alteration of Blood-Brain-Barrier Permeability at Loss of
Recruiting
- Delirium
-
Berlin, GermanyDepartment of Anesthesiology and Operative Intensive Care Medici
May 5, 2021
Parkinson's Disease Trial in Guangzhou (Autonomic dysfunction)
Recruiting
- Parkinson's Disease
- Autonomic dysfunction
-
Guangzhou, Guangdong, ChinaZhujiang Hospital of Southern Medical University
Jul 22, 2022
Delirium, Postoperative Trial (Dexmedetomidine Injection [Precedex], Lidocaine IV, normal saline)
Not yet recruiting
- Delirium, Postoperative
- Dexmedetomidine Injection [Precedex]
- +2 more
- (no location specified)
Oct 15, 2023
Peanut Allergy, Nut Allergy Trial in Amsterdam (Immune-supportive diet)
Recruiting
- Peanut Allergy
- Nut Allergy
- Immune-supportive diet
-
Amsterdam, NetherlandsOLVG
Feb 1, 2023
IBS - Irritable Bowel Syndrome Trial in Linköping (ReFerm(R))
Completed
- IBS - Irritable Bowel Syndrome
- ReFerm(R)
-
Linköping, SwedenLinköping University Hospital, Linköping, Sweden
Jul 25, 2022